|
(6,205)
|

: Pheburane. ?  »
|
-

ORAL

Granules

PHEBURANE is indicated as adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase. It is indicated in all patients with neonatal-onset presentation (complete enzyme deficiencies, presenting within the first 28 days of life). It is also indicated in patients with late-onset disease (partial enzyme deficiencies, presenting after the first month of life) who have a history of hyperammonaemic encephalopathy.

153 57 34275 00

Lucane Pharma , France

03/2015 - 02/2020

.
, .
.
/
Sodium phenylbutyrate 483 MG/G
Bottle hdpe 174 x G 36

*

*

*
Captcha image

 

.

 
" !
 
209